Mile High Labs

Quick gut check. If a clinician or program operator asked your team:

→ Can you deliver consistent bioavailability across every batch?
→ Is your bioavailability data defensible if someone asks for proof?
→ Can you support oral-only formats at a precise dose?
→ Are you positioned for healthcare-aligned programs now?
→ Are you planning on retrofitting later?

How many could you answer?

If any of those gave you pause, you're not alone. Most ingredient supply chains were built for a different era, and the standards are shifting fast.

We put together a breakdown of what's actually changing and how to evaluate where your team stands.

→ See where your supply chain stands

The Mile High Labs Global Team

The announcement has already happened.

What comes next is understanding what it may mean for the future of cannabinoid products.

The Substance Access Beneficiary Engagement Incentive (BEI) is a pilot evaluating physician-supervised, hemp-derived CBD products in a more structured, outcomes-driven environment.

It’s early. It’s limited. And it’s not broad Medicare coverage.

But it does raise an important question for brands:

If cannabinoid products move closer to healthcare-oriented pathways, is your supply chain built for that future?

That’s the conversation we believe is worth having.

See bio for full blog post.

CBC 2026 wrapped up with a lot of good conversations, familiar faces, and new connections along the way.

Grateful for everyone who stopped by the booth and took the time to connect with our team throughout the week.

Always interesting to step back and see where the industry is headed—and this year definitely brought a lot of energy and fresh ideas to the conversation.

Until next time. 🍻

We’ve been spending a lot of time lately talking with brewers about what’s next.
 
CBD beverages keep coming up — not as a trend, but as a new way to expand what’s already working.
 
We’re heading to Philadelphia next week for the Craft Brewers Conference and looking forward to continuing those conversations in person.
 
If you’re there, let’s connect.
 
____________________________
 
 
📍 Booth 433 | Craft Brewers Conference | Philadelphia | April 20–22 | Brewers Association
 
Or feel free to DM us ahead of the show — always happy to start the conversation early.

CBD beverages are showing up in new places — and craft brewers are paying attention.

We’re heading to Philadelphia this April for the Craft Brewers Conference — looking forward to some really good conversations.

CBD beverages are starting to carve out a new space in the craft world — not as a replacement, but as an extension of what brewers already do best: create thoughtful, differentiated experiences.

As that shift continues, the questions we’re hearing are evolving too:
↳ How do you formulate something that actually works in a beverage?
↳ How do you scale it without compromising quality?
↳ How do you navigate what’s next globally?

That’s where we’ve been spending our time.

If you’re attending, come meet the team working closely with brands to bring these products to life.

No hard pitch — just a chance to connect, share ideas, and talk about where things are heading.

____________________________

📍 Booth 433 | Craft Brewers Conference | Philadelphia | April 20–22

Let’s connect in Philadelphia. Brewers Association

Or feel free to DM us ahead of the show — always happy to start the conversation early.

A quick look inside the warehouse.

CBD and CBG are stocked on the shelves and ready to ship when partners need them. Consistent supply makes planning easier—and partnerships stronger.

Ten years ago, Mile High Labs was just an idea taking shape.

Founded by Stephen Mueller, the early days were about building something real — applying science, scaling responsibly, and creating infrastructure for an industry that was still finding its footing.

From lab-scale experiments to an industrial facility in Loveland, Colorado, those early milestones helped shape the journey we’re still on today.

Ten years in. Still here. Still evolving.

Ten years ago, we started building something we truly believed in.

Today, we’re celebrating 10 years of care, innovation, and showing up for our partners and this industry.

This is more than business to us — it’s our life’s work.

More stories coming soon.
Here’s to what’s next.

Every January brings a familiar conversation back into focus.

Dry January offers a clearer view into how beverage choice is evolving.

We shared a few thoughts on what this signals for ingredient-led, CBD, and non-alcoholic beverages — and how brands are planning beyond January.

Link in bio.

2025, by the numbers — built on compliance, quality, and safety.

• 676 million milligrams of water-soluble CBD isolate formulated into beverage brand products
• Shipped globally to 31 countries
• 542% year-over-year growth in CBD 2.0 sales

This progress didn’t come from shortcuts. It came from engineering precision into every ingredient and validating compliance across global markets—from the U.S. to the UK, EU, and Japan.

Thank you for being part of the journey. We’re excited for what’s ahead in 2026.